Spikes Asia

Prescription of Hope – diabetes patient support program

HAVAS HEALTH, Tokyo / SANOFI AVENTIS / 2016

Presentation Image
Case Film

Overview

Entries

Credits

Overview

Background

Insulin injections, while effective, are often perceived as a last resort, leaving patients despondent and uneager to undergo treatment. Especially in Japan, almost all patients feel a sense of despair when they are told they need insulin injection treatment to cope with diabetes.

They feel hopeless, ashamed and alone that they need to embark on a fight that will last their lifetime. Thus, many that do begin receiving insulin treatment quit the process at some point along the way. As a result, the onus on medical professionals to persuade and encourage reluctant patients continues to grow. It was necessary to develop a support program that will remove patient’s anxiety and give morale support and practical advice so that patients could feel comfortable with insulin injections, focus on the treatment and live a better life.

Execution

“Prescription of Hope” support program is a 3 months intensive program provided to patients who are starting on or already being prescribed LANTUS XR (insulin injection treatment). The Starter Kit booklet, prescribed by doctors together with medicine, includes all the basic information pertaining to the disease and treatment to support patients who have any concerns and anxieties. Patients are encouraged to register to the program to receive any or a combination of the following support from the program: (1) HCP support via phone to seek advice on insulin injection, general information on diabetes and to address any concerns (2) subscription of periodicals (physical or digital) to read about the disease, treatment, and practical everyday life tips such as meals and how to act in times of emergency etc. and (3) use of digital app to monitor injection schedules, glucose levels, everyday meals etc.

Similar Campaigns

12 items

LYNX "Magic Salon"

ISOBAR CHINA GROUP, Shanghai

LYNX "Magic Salon"

2018, LYNX

(opens in a new tab)